Probably, biopsy analysis for the virus receptor expression, PD1/PD1L expression, immune cell composition, as well as for such cytokines as TGFβ and IL-10 would help to establish efficient personalized cancer immunotherapy with available “off-the-shelf” virus vectors. The gene discussed is IL10; the disease is cancer.